Jounce Therapeutics Inc. (JNCE) Dipped -11.01% or -0.35 To Price $2.83 On Thursday


Jounce Therapeutics Inc. (JNCE) dipped -11.01% or -0.35 to $2.83. It is around 987375 shares traded, which is 311.61% compare to the average total volume 316864. The market cap of JNCE is $92.54 million. The year to date change is -87.27%. The 52 week price range is from $2.78 to $29.25. Price of JNCE have changed -13.82% during last week. It have changed -30.72% over last month, -52.47% over last 3 months, -59.85% over last 6 months and -76.27% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for JNCE is 4.72. It is 66.78% above current price. The 200-day Moving Averages for JNCE is 10.63. It is 275.62% above current price. The 52-week High is 29.25. It is 933.57% from the current price. The 52-week Low is 2.78. It is -1.77% from current price.

There are some statistics of JNCE. It is has market cap $92.54 million. The share outstanding is 32.70 million. The average volume is 316864. The percent of top 15 Institution holding is 108.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of JNCE is -24.92%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of JNCE is -12.59%.


Tags:

Share this post